Sponsored by: GE Healthcare

Molecular Imaging: Page 105

PET/CT & second tumors; rapid prototyping; JFR congress
By Philip Ward
October 18, 2011
Siemens nets its first U.K. PET/MRI sale
By AuntMinnieEurope.com staff writers
Siemens Healthcare has delivered the first Biograph mMR PET/MRI scanner sold in the U.K. to the new University College Hospital Macmillan Cancer Centre under construction in London.
October 18, 2011
2011 10 19 10 06 04 393 2011 10 19 Siemens
GE inks PET deal with AAA
By AuntMinnieEurope.com staff writers
GE Healthcare has signed a manufacturing agreement with Advanced Accelerator Applications (AAA), based in Bourg-en-Bresse, France, to establish a European PET tracer distribution network over the next few years.
October 18, 2011
EANM: PET/CT proves value in detecting second tumors
By Philip Ward
Results from a large study have confirmed that PET/CT is a powerful technique for the preclinical detection of second primary tumors in oncology patients. The findings were presented at this week's European Association of Nuclear Medicine (EANM) annual congress, held in Birmingham, U.K.
October 18, 2011
2011 10 19 08 26 23 303 2011 10 19 Eanm2 Thumb
Philips opens research unit in Eindhoven
By AuntMinnieEurope.com staff writers
Philips Healthcare has opened a dedicated facility to conduct research on healing environments to accelerate and improve treatment outcomes at its Eindhoven-based research laboratories in the Netherlands.
October 17, 2011
GE enhances PET tracer production
By AuntMinnieEurope.com staff writers
GE Healthcare announced that it has signed a manufacturing agreement with Advanced Accelerator Applications to establish a pan-European PET tracer production facility.
October 17, 2011
OctreoPharm gets orphan drug approval
By AuntMinnieEurope.com staff writers
German nuclear medicine contrast company OctreoPharm Sciences has obtained orphan drug status for its SOMscan contrast agent for diagnosis of gastro-entero-pancreatic neuroendocrine tumors from the European Medicines Agency.
October 12, 2011
Definiens provides boost for biomarkers
By AuntMinnieEurope.com staff writers
Imaging software developer Definiens has announced the release of its quantitative digital pathology portfolio designed to advance translational research in pathology, specifically biomarker development.
October 11, 2011
ESR focuses attention on personalized medicine
By Philip Ward
The era of personalized medicine has major implications for medical imaging and will bring considerable changes in the years ahead, predicts a European Society of Radiology (ESR) white paper. Find out more in our news report.
October 11, 2011
2011 10 12 11 09 04 145 Padhani Esr 12oct11 Thumb
Agfa launches new nuclear medicine PACS
By AuntMinnieEurope.com staff writers
Agfa Healthcare is using the venue of the 2011 Congress of the European Association of Nuclear Medicine later this week to introduce the newest version of its Impax for Nuclear Medicine PACS.
October 9, 2011
OctreoPharm signs deal with Novartis
By AuntMinnieEurope.com staff writers
German nuclear medicine contrast company OctreoPharm Sciences has received the worldwide exclusive license for the development and commercialization of SOMscan from Novartis Pharma.
October 9, 2011
Researchers must manage unexpected findings, report urges
By Cynthia E. Keen
To ignore the issue of incidental findings is unacceptable. Imaging research centers must manage these findings as if they were a medical issue, and they need to establish specific and detailed guidelines and protocols to manage abnormal findings, ranging from life-threatening to minor.
October 3, 2011
Previous Page
Page 105 of 122
Next Page